United Capital Financial Advisers, LLC Moderna, Inc. Transaction History

United Capital Financial Advisers, LLC

  • $11.7 Billion
  • Q4 2024

A detailed history of United Capital Financial Advisers, LLC transactions in Moderna, Inc. stock. As of the latest transaction made, United Capital Financial Advisers, LLC holds 9,059 shares of MRNA stock, worth $281,644. This represents 0.0% of its overall portfolio holdings.

Number of Shares
9,059
Previous 6,087 48.83%
Holding current value
$281,644
Previous $406,000 7.39%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025
BUY
$36.85 - $63.93 $109,518 - $189,999
2,972 Added 48.83%
9,059 $376,000
Q3 2024

Nov 12, 2024
SELL
$63.64 - $125.14 $299,108 - $588,158
-4,700 Reduced 43.57%
6,087 $406,000
Q2 2024

Aug 14, 2024
BUY
$101.21 - $166.61 $89,368 - $147,116
883 Added 8.92%
10,787 $1.28 Million
Q1 2024

May 15, 2024
BUY
$85.37 - $115.44 $95,955 - $129,754
1,124 Added 12.8%
9,904 $1.06 Million
Q4 2023

Feb 14, 2024
BUY
$69.51 - $104.43 $212,144 - $318,720
3,052 Added 53.28%
8,780 $873,000
Q3 2023

Nov 14, 2023
SELL
$96.41 - $126.61 $187,035 - $245,623
-1,940 Reduced 25.3%
5,728 $591,000
Q2 2023

Aug 14, 2023
SELL
$118.5 - $160.53 $213,300 - $288,954
-1,800 Reduced 19.01%
7,668 $931,000
Q1 2023

Aug 14, 2023
BUY
$135.66 - $197.02 $244,188 - $354,636
1,800 Added 23.47%
9,468 $1.45 Million
Q1 2023

May 15, 2023
SELL
$135.66 - $197.02 $320,021 - $464,770
-2,359 Reduced 19.95%
9,468 $1.45 Million
Q4 2022

Feb 14, 2023
BUY
$118.38 - $210.04 $31,607 - $56,080
267 Added 2.31%
11,827 $2.12 Million
Q3 2022

Nov 14, 2022
BUY
$118.07 - $194.18 $80,287 - $132,042
680 Added 6.25%
11,560 $1.37 Million
Q2 2022

Aug 11, 2022
SELL
$117.13 - $176.59 $44,040 - $66,397
-376 Reduced 3.34%
10,880 $1.55 Million
Q1 2022

May 16, 2022
SELL
$126.46 - $235.05 $73,473 - $136,564
-581 Reduced 4.91%
11,256 $1.94 Million
Q4 2021

Feb 14, 2022
SELL
$225.82 - $368.51 $46,067 - $75,176
-204 Reduced 1.69%
11,837 $3.01 Million
Q3 2021

Nov 15, 2021
BUY
$221.9 - $484.47 $41,717 - $91,080
188 Added 1.59%
12,041 $4.63 Million
Q2 2021

Aug 13, 2021
BUY
$129.91 - $234.98 $18,577 - $33,602
143 Added 1.22%
11,853 $2.79 Million
Q1 2021

May 14, 2021
SELL
$109.18 - $185.98 $19,215 - $32,732
-176 Reduced 1.48%
11,710 $1.53 Million
Q4 2020

Feb 17, 2021
BUY
$65.74 - $169.86 $127,667 - $329,868
1,942 Added 19.53%
11,886 $1.24 Million
Q3 2020

Nov 13, 2020
BUY
$54.34 - $94.85 $253,822 - $443,044
4,671 Added 88.58%
9,944 $704,000
Q2 2020

Aug 13, 2020
BUY
$29.67 - $80.0 $156,449 - $421,840
5,273 New
5,273 $339,000

Others Institutions Holding MRNA

# of Institutions
923
Shares Held
255M
Call Options Held
19M
Put Options Held
24.3M
View Full List

About Moderna, Inc.

MRNA Quotes by TradingView
  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $12.2B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track United Capital Financial Advisers, LLC Portfolio

Follow United Capital Financial Advisers, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of United Capital Financial Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on United Capital Financial Advisers, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email